| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| OTLK | Outlook Therapeutics, Inc. | Evanson Jeff | CHIEF COMMERCIAL OFFICER | Mar 07, 2024 | Buy | $0.42 | 62,484 | 26,243 | 808,459 | Mar 11, 2024, 04:43 PM | |
| OTLK | Outlook Therapeutics, Inc. | Evanson Jeff | Chief Commercial Officer | Jan 20, 2023 | Sale | $1.11 | 267,000 | 296,370 | 745,975 | Jan 24, 2023, 08:08 PM | |
| OTLK | Outlook Therapeutics, Inc. | Evanson Jeff | Chief Commercial Officer | Jan 19, 2023 | Sale | $1.22 | 103,255 | 125,971 | 1,012,975 | Jan 19, 2023, 08:05 PM | |
| OTLK | Outlook Therapeutics, Inc. | Evanson Jeff | Chief Commercial Officer | Jan 17, 2023 | Sale | $1.31 | 27,162 | 35,582 | 1,149,968 | Jan 19, 2023, 08:05 PM | |
| OTLK | Outlook Therapeutics, Inc. | Evanson Jeff | Chief Commercial Officer | Jan 18, 2023 | Sale | $1.25 | 33,738 | 42,173 | 1,116,230 | Jan 19, 2023, 08:05 PM | |
| OTLK | Outlook Therapeutics, Inc. | Evanson Jeff | Chief Commercial Officer | Dec 03, 2021 | Buy | $1.34 | 35,200 | 47,168 | 1,177,130 | Dec 06, 2021, 05:25 PM | |
| OTLK | Outlook Therapeutics, Inc. | Evanson Jeff | Chief Commercial Officer | Feb 23, 2021 | Sale | $2.09 | 8,554 | 17,861 | 1,141,930 | Feb 25, 2021, 08:52 PM | |
| OTLK | Outlook Therapeutics, Inc. | Evanson Jeff | Chief Commercial Officer | Feb 12, 2021 | Sale | $2.55 | 56,973 | 145,281 | 1,150,484 | Feb 17, 2021, 09:14 PM |
Menu